A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency
NCT07711158
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Factor VII Deficiency
Interventions
DRUG:
SR604
Sponsor
Shanghai RAAS Blood Products Co., Ltd.